RSNHF(RSNHF)
RSNHF
No analyst ratings available
No analyst price targets available for RSNHF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $903.87B | $1.00T | $1.08T | $1.81T | $2.16T |
| Low | $867.74B | $921.29B | $1.01T | $1.70T | $2.02T |
| High | $986.15B | $1.07T | $1.16T | $1.94T | $2.32T |
| EBITDA Avg | $270.82B | $300.95B | $322.94B | $541.72B | $646.27B |
| Low | $259.99B | $276.04B | $302.75B | $507.86B | $605.88B |
| High | $295.47B | $319.14B | $347.14B | $582.31B | $694.70B |
| EBIT Avg | $234.28B | $260.35B | $279.37B | $468.63B | $559.08B |
| Low | $224.92B | $238.80B | $261.91B | $439.34B | $524.14B |
| High | $255.61B | $276.09B | $300.31B | $503.75B | $600.98B |
| Net Income Avg | $326.11B | $389.81B | $424.87B | $420.90B | $394.01B |
| Low | $299.62B | $358.14B | $390.35B | $386.70B | $362.00B |
| High | $357.88B | $427.78B | $466.26B | $461.90B | $432.40B |
| EPS Avg | $143.46 | $171.49 | $186.91 | $185.16 | $173.34 |
| Low | $131.81 | $157.55 | $171.72 | $170.12 | $159.25 |
| High | $157.44 | $188.19 | $205.12 | $203.20 | $190.22 |
| Analysts (Rev / EPS) | 7 / 1 | 7 / 1 | 5 / 1 | 3 / 1 | 5 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $215.93B | $224.78B | $244.97B | $260.15B | $255.82B | $263.65B | $277.52B | $295.69B |
| Low | $204.08B | $212.45B | $231.53B | $245.88B | $241.78B | $249.19B | $262.29B | $279.47B |
| High | $227.77B | $237.11B | $258.41B | $274.43B | $269.85B | $278.12B | $292.74B | $311.91B |
| EBITDA Avg | $64.70B | $67.35B | $73.40B | $77.95B | $76.65B | $79.00B | $83.15B | $88.60B |
| Low | $61.15B | $63.65B | $69.37B | $73.67B | $72.44B | $74.66B | $78.59B | $83.74B |
| High | $68.25B | $71.04B | $77.43B | $82.22B | $80.85B | $83.33B | $87.71B | $93.46B |
| EBIT Avg | $55.97B | $58.26B | $63.50B | $67.43B | $66.31B | $68.34B | $71.93B | $76.64B |
| Low | $52.90B | $55.07B | $60.01B | $63.73B | $62.67B | $64.59B | $67.99B | $72.44B |
| High | $59.04B | $61.46B | $66.98B | $71.13B | $69.95B | $72.09B | $75.88B | $80.85B |
| Net Income Avg | $77.35B | $85.40B | $74.91B | $96.98B | $93.45B | $99.78B | $103.92B | $111.59B |
| Low | $71.83B | $79.31B | $69.57B | $90.06B | $86.79B | $92.66B | $96.51B | $103.64B |
| High | $82.86B | $91.49B | $80.26B | $103.89B | $100.12B | $106.90B | $111.33B | $119.55B |
| EPS Avg | $34.60 | $38.20 | $33.51 | $43.38 | $41.80 | $44.63 | $46.49 | $49.92 |
| Low | $32.13 | $35.48 | $31.12 | $40.29 | $38.82 | $41.45 | $43.17 | $46.36 |
| High | $37.07 | $40.93 | $35.90 | $46.47 | $44.79 | $47.82 | $49.80 | $53.48 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |